Epirubicin (E) in combination with cisplatin (CDDP) and capecitabine (C) versus docetaxel (D) combined with 5-fluorouracil (5-FU) by continuous infusion as front-line therapy in patients with advanced gastric cancer (AGC): Preliminary results of a randomized phase II trial of the Gruppo Oncologico Dell'Italia Meridionale

被引：4
|
作者：
Maiello, E.
De Vita, F.
Gebbia, V.
Lorusso, V.
Cinieri, S.
Giuliani, F., Sr.
Orditura, M.
Fistola, E.
Filippelli, G.
Colucci, G., Sr.
机构：
[1] Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] Univ Naples 2, Div Med Oncol, Naples, Italy
[3] La Maddalena Clin, Palermo, Italy
[4] Osped Vito Fazzi, Lecce, Italy
[5] Sen Antonio Perrino Hosp, Brindisi, Italy
[6] NCI, Bari, Italy
[7] Div Med Oncol, Naples, Italy
[8] Med Oncol Unit, Bari, Italy
[9] Osped S Francesco Paola, Paola, Italy
[10] Ist Oncol Bari, Bari, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.97
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
97
引用
收藏
页数：1
相关论文
共 31 条
  • [1] EPIRUBICIN (E) IN COMBINATION WITH CISPLATIN (CDDP) AND CAPECITABINE (C) VERSUS DOCETAXEL (D) COMBINED WITH 5-FLUOROURACIL (5-FU) BY CONTINUOUS INFUSION (CI) AS FRONT-LINE THERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER (AGC): PRELIMINARY RESULTS OF A RANDOMISED PHASE II TRIAL OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE
    Silvestris, N.
    De Vita, F.
    Romano, M. P.
    Maiello, E.
    Gebbia, V.
    Lorusso, V.
    Cinieri, S.
    Giuliani, F.
    Orditura, M.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 227 - 227
  • [2] Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
    De Vita, F.
    Giuliani, F.
    Orditura, M.
    Maiello, E.
    Galizia, G.
    Di Martino, N.
    Montemurro, F.
    Carteni, G.
    Manzione, L.
    Romito, S.
    Gebbia, V.
    Ciardiello, F.
    Catalano, G.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (08) : 1354 - 1358
  • [3] Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC):: a randomised phase III trial
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Philco, M.
    Suarez, T.
    Santamaria, J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 259 - 259
  • [4] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Salas, M.
    Suarez, T.
    Santamaria, J.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 19 - 19
  • [5] Randomized Prospective Phase II Study to Compare the Combination Chemotherapy Regimen Epirubicin, Cisplatin, and 5-Fluorouracil With Epirubicin, Cisplatin, and Capecitabine in Patients With Advanced or Metastatic Gastric Cancer
    Ocvirk, Janja
    Rebersek, Martina
    Skof, Erik
    Hlebanja, Zvezdana
    Boc, Marko
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 237 - 241
  • [6] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results.
    Kang, Y.
    Kang, W. K.
    Shin, D. B.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Salas, M. P.
    Suarez, T.
    Santamaria, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 183S - 183S
  • [7] Surgery plus ELFE (epirubicin, leucovorin, 5-fluorouracil and etoposide) vs surgery alone in radically resected gastric cancer (GC): Final results of a randomised phase III trial by the Gruppo Oncologico dell' Italia Meridionale (GOIM).
    De Vita, F.
    Giuliani, F.
    Gebbia, V.
    Galizia, G.
    Orditura, M.
    Maiello, E.
    Romito, S.
    Carteni, G.
    Manzione, L.
    Catalano, G.
    Colucci, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 182S - 182S
  • [8] Preoperative low dose continuous infusion of 5-fluorouracil (5-FU) with cisplatin for potentially unresectable advanced gastric cancer (AGC) with extensive lymph node metastasis: a phase II study
    Chin, KC
    Imazu, HI
    Mochiki, EM
    Tokunaga, AT
    Hosoya, YH
    Tsujitani, ST
    Nakajima, TN
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 251 - 252
  • [9] Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
    Kang, Y. -K.
    Kang, W. -K.
    Shin, D. -B.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Guan, Z.
    Khasanov, R.
    Zheng, L.
    Philco-Salas, M.
    Suarez, T.
    Santamaria, J.
    Forster, G.
    McCloud, P. I.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (04) : 666 - 673
  • [10] Cisplatin (P) Combined with Docetaxel (T) or Vinorelbine (V) as Front-Liner Therapy in Patients with Advanced Non-Small Cell Lung Cancer: A Randomised Phase II Trial of the Gruppo Oncologico Italia Meridionale
    Gebbia, V.
    Lorusso, V.
    Galetta, D.
    Caruso, M.
    Maiello, E.
    Riccardi, F.
    Carrozza, F.
    Borsellino, N.
    Leo, S.
    Ferrau, F.
    Cinieri, S.
    Colucci, G.
    [J]. ONCOLOGY, 2009, 77 : 145 - 146
1234